Emergent BioSolutions Inc.EBSNYSE
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+58.5%
5Y CAGR+36.5%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+58.5%/yr
vs +39.3%/yr prior
5Y CAGR
+36.5%/yr
Recent acceleration
Acceleration
+19.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.7x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$148.50M+109.2%
2024$71.00M-19.2%
2023$87.90M+135.7%
2022$37.30M+8.1%
2021$34.50M+10.2%
2020$31.30M-18.5%
2019$38.40M+287.9%
2018$9.90M+50.2%
2017$6.59M-13.5%
2016$7.62M-